Pillstats
Rx only · Spray, Metered · Respiratory (Inhalation)

Ipratropium Bromide And Albuterol

Brands: Combivent Respimat · Albuterol Sulfate + Ipratropium Bromide

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)203212
US makers1 labelers
Packages1
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$35.73$71.46$107.20$142.93Jan 2026Jun 2026Jul 2026
$124.178
Latest avg · Jul 22, 2026
-0%
Since Jan 1, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

27K54K80K107K2025 Q12025 Q22025 Q32025 Q42026 Q1
73K
Rx · 2026 Q1
316K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Boehringer Ingelheim Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 24, 2015
    RECALLRecall (Class II): COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Me…

    Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray. — Recalling firm: Boehringer Ingelheim Roxane Inc — Nationwide and Puerto Rico